Synthesis, antiviral evaluation, molecular docking study and cytotoxicity of 5′-phosphorylated 1,2,3-triazolyl nucleoside analogues with thymine and 6-methyl uracil moieties

Bulat F. Garifullin,Dmitry A. Tatarinov,Olga V. Andreeva,Mayya G. Belenok,Irina Yu. Strobykina,Leysan R. Khabibulina,Anna V. Shepelina,Vladimir V. Zarubaev,Alexander V. Slita,Alexandrina S. Volobueva,Alexandra D. Voloshina,Anna P. Lyubina,Liliya E. Saifina,Vyacheslav E. Semenov,Vladimir E. Kataev
DOI: https://doi.org/10.1007/s00044-023-03112-z
2023-06-24
Medicinal Chemistry Research
Abstract:A comparative analysis of in vitro antiviral activity (in terms of the concentration of semi-maximal inhibition, IC 50 ) against influenza virus A/PR/8/34 (H1N1) of a large series of parent 1,2,3-triazolyl nucleoside analogues (with uracil, thymine, 6-methyluracil, quinazoline-2,4-dione moieties as nucleic bases) and their prodrug forms with masked 5ʹ-phosphate groups (diethyl phosphate, diphenyl phosphate, phosphoramidate) and negatively charged H -phosphonate and monophosphate groups was carried out. Obtained structure-activity relationships were interpreted based on the assumption that the synthesized parent 1,2,3-triazolyl nucleoside analogues and their prodrug forms, by analogy with the literature data, are metabolized by cellular kinases to their active 5ʹ-triphosphate forms that inhibit the activity of viral RNA-dependent RNA polymerase (RdRp). A correlation was found between the experimental values of IC 50 and the theoretical values of the binding energies of 5ʹ-triphosphate derivatives of the parent 1,2,3-triazolyl nucleoside analogues in the active site of RdRp.
chemistry, medicinal
What problem does this paper attempt to address?